STOCK TITAN

Check Point director granted RSUs, 15,000 options

CHKP director Yoav Chelouche received new RSU and stock option grants that increase his direct and option-based ownership stakes.

(Very High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CHECK POINT SOFTWARE TECHNOLOGIES LTD (CHKP) reported that director Yoav Chelouche received equity awards on September 2, 2026. He was granted 1,120 Restricted Share Units (RSUs), each representing one Ordinary Share upon vesting, and stock options for 15,000 Ordinary Shares at an exercise price of $133.89 per share, expiring September 1, 2033. The RSUs and options vest in three tranches during 2027, subject to his continued service. Following these awards, he holds 5,128 Ordinary Shares directly and options over 75,000 Ordinary Shares, of which 60,000 were vested as of September 3, 2026. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Chelouche Yoav
Role Director
Type Security Shares Price Value
Grant/Award Stock Options F3, F4 15,000 $133.89 $2.01M
Grant/Award Ordinary Shares, NIS 0.01 Per Share F1, F2 1,120 $0.00 $0.00
Holdings After Transaction: Stock Options — 15,000 contracts (Direct); Ordinary Shares, NIS 0.01 Per Share — 5,128 shares (Direct)
Footnotes (4)
  1. F1. The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs) that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
  2. F2. Includes 1,120 RSUs that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
  3. F3. The Reporting Person was granted by the Issuer options to purchase 15,000 Ordinary Shares that are scheduled to vest as follows: 7,500 on March 2, 2027, 3,750 on June 2, 2027, 3,750 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date.
  4. F4. In addition, there are 60,000 Ordinary Shares underlying options held by the Reporting Person, of which 60,000 are vested as of September 3, 2026.
RSUs granted 1,120 units Restricted Share Units granted to Yoav Chelouche on September 2, 2026
Stock options granted 15,000 options Options to purchase Ordinary Shares granted on September 2, 2026
Option exercise price $133.89 per share Exercise price for the 15,000 stock options expiring September 1, 2033
Post-transaction share holdings 5,128 Ordinary Shares Direct CHKP share ownership by Yoav Chelouche after the RSU grant
Total options held 75,000 options Ordinary Shares underlying options held, including 60,000 vested as of September 3, 2026
RSU vesting dates March 2, 2027; June 2, 2027; September 2, 2027 Three scheduled vesting dates for the 1,120 RSUs
Option vesting dates March 2, 2027; June 2, 2027; September 2, 2027 Three scheduled vesting dates for the 15,000 stock options
Restricted Share Units (RSUs) financial
"The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs)"
Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.
Ordinary Shares financial
"Each RSU represents the right to receive one Ordinary Share of the Issuer"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
exercise price financial
"options to purchase 15,000 Ordinary Shares with an exercise price reference"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"that are scheduled to vest as follows: 560 on March 2, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Service Provider financial
"subject to the Reporting Person's continued service as a Service Provider"

FAQ

What equity awards did CHKP grant to director Yoav Chelouche on September 2, 2026?

On September 2, 2026, Yoav Chelouche received 1,120 RSUs and stock options for 15,000 Ordinary Shares of CHKP at an exercise price of $133.89 per share, with the options expiring on September 1, 2033.

How do the new CHKP RSUs granted to Yoav Chelouche vest?

The 1,120 RSUs vest in three installments in 2027: 560 on March 2, 280 on June 2, and 280 on September 2, 2027, subject to Yoav Chelouche’s continued service as a Service Provider on each vesting date.

What is the vesting schedule for the 15,000 CHKP stock options granted to Yoav Chelouche?

The 15,000 CHKP stock options vest as follows: 7,500 options on March 2, 2027, 3,750 on June 2, 2027, and 3,750 on September 2, 2027, subject to his continued service on each vesting date.

What are Yoav Chelouche’s CHKP share and option holdings after these transactions?

After the reported awards, Yoav Chelouche directly holds 5,128 Ordinary Shares of CHKP and options over 75,000 Ordinary Shares, including 60,000 options that were vested as of September 3, 2026.

Were Yoav Chelouche’s CHKP equity awards made under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 trading plan for these transactions, meaning they are reported without an affirmed pre-arranged trading plan under Rule 10b5-1.

Did Yoav Chelouche pay any price for the newly acquired CHKP Ordinary Shares?

The 1,120 Ordinary Shares underlying the RSU grant are shown with a $0.00 transaction price per share, reflecting that they are part of a restricted share unit award rather than a cash share purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chelouche Yoav

(Last)(First)(Middle)
5 SHLOMO KAPLAN STREET

(Street)
TEL AVIV6789159

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
CHECK POINT SOFTWARE TECHNOLOGIES LTD [ CHKP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares, NIS 0.01 Per Share09/02/2026A(1)1,120A$0.005,128(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options$133.8909/02/2026A15,000 (3)09/01/2033Ordinary Shares15,000$133.8915,000(4)D
Explanation of Responses:
1. The Reporting Person was granted by the Issuer 1,120 Restricted Share Units (RSUs) that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
2. Includes 1,120 RSUs that are scheduled to vest as follows: 560 on March 2, 2027, 280 on June 2, 2027, 280 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date. Each RSU represents the right to receive one Ordinary Share of the Issuer upon vesting and settlement.
3. The Reporting Person was granted by the Issuer options to purchase 15,000 Ordinary Shares that are scheduled to vest as follows: 7,500 on March 2, 2027, 3,750 on June 2, 2027, 3,750 on September 2, 2027, subject to the Reporting Person's continued service as a Service Provider of the Issuer on each vesting date.
4. In addition, there are 60,000 Ordinary Shares underlying options held by the Reporting Person, of which 60,000 are vested as of September 3, 2026.
/S/ Shira Yashar - Attorney-in-Fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)